Injectable long-acting progestogen contraception: A neglected modality

A G Rosenfield, Allan Rosenfield
American Journal of Obstetrics and Gynecology · 1974 · vol. 120(4) , pp. 537–548 · doi:10.1016/0002-9378(74)90633-4 · PMID:4606673 · W1770801808
review OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-13 ⓘ

This paper reviews injectable long-acting progestogen contraception, highlighting its current status and potential impact.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Contraceptive Agents, Female Medroxyprogesterone Adult Amenorrhea Amenorrhea Breast Neoplasms Breast Neoplasms Contraceptive Agents, Female Delayed-Action Preparations Endometriosis Endometriosis Endometrium Endometrium Estrogen Antagonists Family Planning Services Female Fertility Fertility Glucose Glucose

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (58)

Source provenance

europepmc
last seen: 2026-06-13T06:22:48.782012+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-14T05:59:03.573854+00:00
License: CC0 · commercial use OK